Marios Pillas1, Caroline Selai2, Niall P Quinn2, Andrew Lees2, Irene Litvan3, Anthony Lang4, James Bower5, David Burn6, Philip Low5, Anette Schrag7. 1. Faculty of Social and Human Sciences, University of Southampton, Southampton, UK. 2. Department of Clinical Neurosciences, UCL Institute of Neurology, University College London, London, UK. 3. Movement Disorder Program, Department of Neurology, University of Louisville, Louisville, KY, USA. 4. Toronto Western Hospital and the University of Toronto, Toronto, ON, Canada. 5. Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN, USA. 6. Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, UK. 7. Department of Clinical Neurosciences, UCL Institute of Neurology, University College London, London, UK. a.schrag@ucl.ac.uk.
Abstract
PURPOSE: Atypical parkinsonism (AP) has a considerable impact on the lives not only of patients but also of their carers. The aim of this study was to develop an instrument for assessing the quality of life (QoL) of carers of patients with AP. METHODS: A 40-item pool was generated from in-depth interviews with carers of patients with AP, a thorough review of the existing literature and consultation with movement disorder experts. Item refinement and reduction was performed using the results of pilot testing and a survey in 282 carers of multiple system atrophy (MSA) patients and 226 carers of progressive supranuclear palsy (PSP) patients. A validation study, with responses of 243 carers of MSA and 187 carers of PSP patients, was undertaken to evaluate the psychometric properties of the final 26-item scale. RESULTS: The validation study results suggest that the scale is unidimensional and has high internal consistency (Cronbach's α = 0.96). The correlations of scale scores with patients' health status and QoL measures, such as PDQ-39 summary score and EQ-5D index (Spearman's ρ = 0.56 and -0.31, respectively, P < 0.001), as well as carers' measures, such as Caregiver Burden Inventory (CBI) total and EQ-5D index (Spearman's ρ = 0.85 and -0.39, respectively, P < 0.001), document the convergent and concurrent validity of the scale. ANOVA results support the discriminant validity of the scale, as evidenced by its capacity to differentiate between carers with varying levels of self-reported health. CONCLUSIONS: The 26-item Parkinsonism Carers QoL (PQoL Carer) is a concise instrument with adequate psychometric qualities that can be used for clinical and research purposes.
PURPOSE:Atypical parkinsonism (AP) has a considerable impact on the lives not only of patients but also of their carers. The aim of this study was to develop an instrument for assessing the quality of life (QoL) of carers of patients with AP. METHODS: A 40-item pool was generated from in-depth interviews with carers of patients with AP, a thorough review of the existing literature and consultation with movement disorder experts. Item refinement and reduction was performed using the results of pilot testing and a survey in 282 carers of multiple system atrophy (MSA) patients and 226 carers of progressive supranuclear palsy (PSP) patients. A validation study, with responses of 243 carers of MSA and 187 carers of PSPpatients, was undertaken to evaluate the psychometric properties of the final 26-item scale. RESULTS: The validation study results suggest that the scale is unidimensional and has high internal consistency (Cronbach's α = 0.96). The correlations of scale scores with patients' health status and QoL measures, such as PDQ-39 summary score and EQ-5D index (Spearman's ρ = 0.56 and -0.31, respectively, P < 0.001), as well as carers' measures, such as Caregiver Burden Inventory (CBI) total and EQ-5D index (Spearman's ρ = 0.85 and -0.39, respectively, P < 0.001), document the convergent and concurrent validity of the scale. ANOVA results support the discriminant validity of the scale, as evidenced by its capacity to differentiate between carers with varying levels of self-reported health. CONCLUSIONS: The 26-item Parkinsonism Carers QoL (PQoL Carer) is a concise instrument with adequate psychometric qualities that can be used for clinical and research purposes.
Entities:
Keywords:
Atypical parkinsonism; Instrument validation; Patient carers; Quality of life
Authors: A Schrag; C Selai; N Quinn; A Lees; I Litvan; A Lang; Y Poon; J Bower; D Burn; J Hobart Journal: Neurology Date: 2006-07-11 Impact factor: 9.910
Authors: Anette Schrag; Felix Geser; Michaela Stampfer-Kountchev; Klaus Seppi; Martin Sawires; Martin Köllensperger; Christoph Scherfler; Niall Quinn; Maria T Pellecchia; Paolo Barone; Francesca Del Sorbo; Alberto Albanese; Karen Ostergaard; Erik Dupont; Adriana Cardozo; Eduardo Tolosa; Christer F Nilsson; Håkan Widner; Olle Lindvall; Nir Giladi; Tanya Gurevich; Christine Daniels; Günther Deuschl; Miguel Coelho; Cristina Sampaio; Michael Abele; Thomas Klockgether; Nicole Schimke; Karla M Eggert; Wolfgang Oertel; Ruth Djaldetti; Carlo Colosimo; Giuseppe Meco; Werner Poewe; Gregor K Wenning Journal: Mov Disord Date: 2006-06 Impact factor: 10.338
Authors: Marina Picillo; Sofia Cuoco; Marianna Amboni; Francesco Paolo Bonifacio; Antonino Bruno; Fabio Bruschi; Arianna Cappiello; Rosa De Micco; Anna De Rosa; Francesca Di Biasio; Francesca Elifani; Roberto Erro; Margherita Fabbri; Marika Falla; Giulia Franco; Daniela Frosini; Sebastiano Galantucci; Giulia Lazzeri; Luca Magistrelli; Maria Chiara Malaguti; Anna Vera Milner; Brigida Minafra; Enrica Olivola; Andrea Pilotto; Cristina Rascunà; Maria Cristina Rizzetti; Tommaso Schirinzi; Barbara Borroni; Roberto Ceravolo; Alessio Di Fonzo; Leonardo Lopiano; Roberta Marchese; Nicola B Mercuri; Nicola Modugno; Alessandra Nicoletti; Alessandro Padovani; Gabriella Santangelo; Alessandro Stefani; Alessandro Tessitore; Maria Antonietta Volontè; Roberta Zangaglia; Mario Zappia; Paolo Barone Journal: Neurol Sci Date: 2019-06-12 Impact factor: 3.307
Authors: Thomas E Page; Nicolas Farina; Anna Brown; Stephanie Daley; Ann Bowling; Thurstine Basset; Gill Livingston; Martin Knapp; Joanna Murray; Sube Banerjee Journal: BMJ Open Date: 2017-03-29 Impact factor: 2.692
Authors: Lukas Kellermair; Alexandra Fuchs; Christian Eggers; Petra Schwingenschuh; Mariella Kögl; Franz Fellner; Thomas Forstner; Stephanie Mangesius; Michael Guger; Gerhard Ransmayr Journal: J Neural Transm (Vienna) Date: 2021-07-22 Impact factor: 3.575
Authors: Brent Bluett; Alexander Y Pantelyat; Irene Litvan; Farwa Ali; Diana Apetauerova; Danny Bega; Lisa Bloom; James Bower; Adam L Boxer; Marian L Dale; Rohit Dhall; Antoine Duquette; Hubert H Fernandez; Jori E Fleisher; Murray Grossman; Michael Howell; Diana R Kerwin; Julie Leegwater-Kim; Christiane Lepage; Peter Alexander Ljubenkov; Martina Mancini; Nikolaus R McFarland; Paolo Moretti; Erica Myrick; Pritika Patel; Laura S Plummer; Federico Rodriguez-Porcel; Julio Rojas; Christos Sidiropoulos; Miriam Sklerov; Leonard L Sokol; Paul J Tuite; Lawren VandeVrede; Jennifer Wilhelm; Anne-Marie A Wills; Tao Xie; Lawrence I Golbe Journal: Front Neurol Date: 2021-07-01 Impact factor: 4.003